 NASHVILLE, Tenn., March 9, 2021 PRNewswire -- Cumberland Pharmaceuticals Inc. NASDAQ: CPIX, a specialty pharmaceutical company focused on hospital acute care, gastroenterology and rheumatology, today announced fourth quarter and full year 2020 financial results. 